Picture of Solventum logo

SOLV — Solventum News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Solventum Corporation reports results for the quarter ended June 30 - Earnings Summary

Solventum Corporation reports results for the quarter ended June 30 - Earnings Summary
  • Solventum Corporation SOLV.N reported quarterly adjusted earnings of $2.55​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.69. The mean expectation of twelve analysts for the quarter was for earnings of $1.91 per share. Wall Street expected results to range from $1.84 to $1.95 per share.

  • Revenue rose 2.2% to $2.21 billion from a year ago; analysts expected $2.16 billion.

  • Solventum Corporation's reported EPS for the quarter was 53 cents​.

  • The company reported quarterly net income of $92 million.

  • Solventum Corporation shares had risen by 14.0% this quarter and gained 11.0% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 0.2% in the last three months.​

  • In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

  • Wall Street's median 12-month price target for Solventum Corporation is $90.00, about 2.8% above its last closing price of $87.47

This summary was machine generated from LSEG data August 5 at 10:39 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

1.91

2.55

Beat

Mar. 31 2026

1.35

1.48

Beat

Dec. 31 2025

1.50

1.57

Beat

Sep. 30 2025

1.43

1.50

Beat

Recent news on Solventum

See all news